Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue

Antiviral Research

Volumn 63, Issue 1, 2004, Pages 61-64

  Bidanset, Deborah J ^a   Rybak, Rachel J ^a   Hartline, Caroll B ^a   Kern, Earl R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Cidofovir; Ganciclovir; Human cytomegalovirus; SCID hu mice

Indexed keywords

CIDOFOVIR; GANCICLOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; LINEAR REGRESSION ANALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RETINA; TREATMENT OUTCOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; CYTOSINE; DISEASE MODELS, ANIMAL; GANCICLOVIR; HUMANS; MICE; MICE, SCID; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 2942532707     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.02.002     Document Type: Article

References (20)

1. Alford, C.A., Britt, W.J., 1993. Cytomegalovirus. In: Roizman, B., Whitley, R.J., Lopez, C. (Eds.), The Human Herpesviruses. Raven Press, New York, pp. 227-255.
2. Bidanset, D.J., del Cerro, M., Lazar, E.S., Faye-Petersen, O., Kern, E.R., 1999. Animal model for ocular human cytomegalovirus infections in SCID-hu mice. In: Zak, O., Sande, M.E. (Eds.), Handbook of Animal Models of Infection. Academic Press, New York, pp. 957-962.
3. Bidanset D.J., Rybak R.J., Hartline C.B., Kern E.R. Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. J. Infect. Dis. 184:2001;192-195
4. Cocohoba J.M., McNicholl I.R. Valganciclovir: an advance in cytomegalovirus therapeutics. Ann. Pharmacother. 36:2002;1075-1079
5. Crumpacker C.S. Ganciclovir. N. Engl. J. Med. 335:1996;721-729
6. DiLoreto D., Epstein L.G., Lazar E.S., Britt W.J., del Cerro M. Cytomegalovirus infection of human retinal tissue: an in vivo model. Lab. Invest. 71:1994;141-148
7. Emery V.C. Cytomegalovirus drug resistance. Antivir. Ther. 3:1993;239-242
8. Epstein L.G., Cvetkovich T.A., Lazar E.S., Dehlinger K., Dzenko K., del Cerro C., del Cerro M. Successful xenografts of second trimester fetal brain and retinal tissue in the anterior chamber of the eye of adult immunosuppressed rats. J. Neural Transplant. Plast. 3:1992;151-158
9. Gershon, A.A., Gold, E., Nankervis, G.A., 1997. Cytomegalovirus. In: Evans, A.S., Kaslow, R.A. (Eds.), Viral Infections of Humans. Plenum Press, New York, pp. 229-251.
10. Jabs, D.A., Martin, B.K., Forman, M.S., Hubbard, L., Dunn, J.P., Kempen, J.H., Davis, J.L., Weinberg, D.V., and the Cytomegalovirus Retinitis and Viral Resistance Study Group., 2003. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am. J. Opthalmol. 135, 26-34.
11. Jacobson M.A. Drug therapy: treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 337:1997;105-114
12. Jacobson M.A., Wilson S., Stanley H., Holtzer C., Cherrington J., Safrin S. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS. Clin. Infect. Dis. 28:1999;528-533
13. Kern E.R., Rybak R.J., Hartline C.B., Bidanset D.J. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus. Antivir. Chem. Chemother. 12(Suppl. 1):2001;149-156
14. Laycock K.A., Fenoglio E.D., Hook K.K., Pepose J.S. An in vivo model of human cytomegalovirus retinal infection. Am. J. Opthamol. 124:1997;181-189
15. Lea A.P., Bryson H.M. Cidofovir. Drugs. 52:1996;225-230
16. Perry C.M., Balfour J.A. Formivirsen. Drugs. 57:1999;375-380
17. Polis M.A. Cytomegalovirus retinitis in persons with AIDS - a shift in the treatment paradigm? Clin. Infect. Dis. 28:1999;534-536
18. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group, 2001. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the ganciclovir cidofovir cytomegalovirus retinitis trial. Am. J. Ophthalmol. 131, 457-467.
19. van der Meer J.T.M., Drew W.L., Bowden R.A., Galasso G.J., Griffiths P.D., Jabs D.A., Katlama C., Spector S.A., Whitley R.J. Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment, and Prophylaxis of Cytomegalovirus Infection. Antivir. Res. 32:1996;119-140
20. Wagstaff A.J., Bryson H.M. Foscarnet: a reappraisal of its antiviral activity, pharmacokinetics properties and therapeutic use in immunocompromised patients. Drugs. 48:1994;199-226